Company: APXIF
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001213900-25-026189
Chunk: 731

Company: APx Acquisition Corp. I
Filing Date: 2025-03-31
Form: 10-K
Item: Item 2
Chunk 731
---
 listing and registration on Nasdaq. Under Rule IM-5101-2, a special purpose
acquisition company must complete one or more business combinations within 36 months of the effectiveness of its initial public
offering registration statement. Since we failed to complete our initial business combination by December 6, 2024, Nasdaq’s
staff concluded that we did not comply with Rule IM-5101-2 and that our securities are now subject to delisting.

As a result, trading in our securities on Nasdaq
was effectively suspended with the open of the market on December 17, 2024, and our securities are currently eligible to trade only
on the over-the-counter markets system.

On March 21, 2025, Nasdaq filed a Form 25-NSE
in respect of our Class A ordinary shares with the SEC, and the delisting of our Class A ordinary shares will become effective on March
31, 2025.

In order to complete the delisting process with
respect to our units and warrants, we expect that Nasdaq will file a Form 25-NSE in respect of such securities with the SEC, and the delisting
will become effective ten days after such Form 25-NSE is filed. Although we expect that we will be notified by Nasdaq prior to the filing
of such Form 25-NSE, as well as prior to the release of a press release by Nasdaq announcing the delisting event, we are not at this time
able to determine when such Form 25-NSE will be filed or when the delisting of our units and warrants from Nasdaq will be complete. However,
the filing of the Form 25-NSE by Nasdaq and the subsequent delisting of our units and warrants may occur at any time without prior notice.

Despite the  delisting of our securities
from Nasdaq, we intend to proceed with our efforts to consummate our initial Business Combination. However, Nasdaq approval of OmnigenicsAI’s
initial listing application with respect to the Business Combination is a condition to such Business Combination, and there can be no
guarantee that Nasdaq will approve such initial listing application, which may delay, or ultimately prevent the consummation of the proposed
Business Combination.

Following the suspension of trading on Nasdaq,
our Class A ordinary shares are quoted on the Pink Open Market of the OTC under the symbol “APXIF”.

Holders 

As of March 31, 2025